Back to the main directory
Company Analysis / Equity
- HUGO BOSS: Q1 sales a touch better but brace for severe turbulences in Q2 | NEUTRAL | EUR64(+145%) by Bryan Garnier
- INFINEON: Infineon guidance disappoints and Cypress acquisition does not help in the short term | NEUTRAL | EUR20(+18%) by Bryan Garnier
- Vermilion Energy - Dividend suspended to protect balance sheet by Edison Investment Research
- Newron Pharmaceuticals - Sarizotan fails to shine by Edison Investment Research
- HUGO BOSS: Severe turbulence in Q2 and a long road ahead to recover from Covid-19 | NEUTRAL | EUR52 vs. EUR64 (+127%) by Bryan Garnier
- LNA SANTÉ: Q1 revenue: situation stabilised and under control | BUY | Under Review by Bryan Garnier
- Riber - Sales cycles longer but MBE demand still strong by Edison Investment Research
- Itaú BBA on Guararapes: Highlights From Webinar With Chairman and CFO by Itau
- Canadian General Investments - Sticking to the fundamental, long-term process by Edison Investment Research
- NOVO NORDISK: Long-term outlook is still brighter than short-term one | NEUTRAL | DKK390 vs. DKK380 (-9%) by Bryan Garnier
- BONE THERAPEUTICS (CORPORATE, FV EUR6) | Additional EUR4m raised, cash runway expanded into Q2 2021: by Bryan Garnier
- LEGRAND: Sales drop in April, improvement subject to health situation improvement | NEUTRAL | EUR63 (+9%) by Bryan Garnier
- AHOLD DELHAIZE: Strong Q1 with 2020 guidance reiterated | BUY | EUR24(+7%) by Bryan Garnier
- AWOX (BUY, FV EUR2.0) | No more dilution coming from existing convertible bonds: by Bryan Garnier
- VALNEVA: A good Q1 but rest of year set to be more difficult | BUY | EUR5,8(+46%) by Bryan Garnier
- RCM Beteiligungs - Realising value through disposals by Edison Investment Research
- Morningstar | Veolia to Continue Delivering Solid Earnings and Dividend Growth Despite Likely Top-Line Slowdown by Morningstar
- Strong Start to Heidelberg’s 2019 in Seasonally Weak First Quarter; Shares Look Undervalued by Morningstar
- Underlying Results Ahead; ASC 606, Marketo, Magento Deals Distort Guidance; FVE Unchanged at $296 by Morningstar
- Business Uncertainty Following Prolonged Brexit Hangs Over RBS' Near-Term Income Outlook by Morningstar
- Daimler's Mercedes-Benz Brand Is a World Leader in Luxury Automobiles by Morningstar
- BD's Integration of Bard on Track by Morningstar
- Morningstar | CME Group Seeks to Diversify Beyond Interest Rates and Equity Futures by Morningstar
- Revenue Prioritized Over Margins in Ericsson's 2Q, Pressure to Continue; Maintaining SEK 81 FVE by Morningstar
- FedEx Demonstrates Discipline, Declines to Renew Amazon Contract with U.S. Express by Morningstar